The Role of Foxo3 in Leydig Cells
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: Foxo3 in female reproduction has been reported to regulate proliferation of granulose cells that form follicles. There are no reports so far that discuss on the role of Foxo3 in males. This study was designed to outline the role of Foxo3 in the testes. Materials and Methods: Testes from mice at birth to postpartum week (PPW) 5 were isolated and examined for the expression of Foxo3 using immunostaining. To elucidate role of Foxo3 in Leydig cells, R2C cells were treated with luteinizing hormone (LH) and the phosphorylation of Foxo3. Testosterone and steroidogenic acute regulatory (StAR) protein levels were measured after constitutive active [triple mutant (TM)] human FOXO3 adenovirus was transduced and StAR promoter assay was performed. Results: Foxo3 expression in the testicles started from birth and lasted until PPW 3. After PPW 3, most Foxo3 expression occurred in the nuclei of Leydig cells; however, at PPW 5, Foxo3 was expressed in both the nucleus and cytoplasm. When R2C cells were treated with luteinizing hormone, Foxo3 phosphorylation levels by AKT increased. After blocking the PI3K pathway, LH-induced phosphorylated Foxo3 levels decreased, indicating that LH signaling regulates Foxo3 localization. When active FOXO3-TM adenoviruswas introduced into a Leydig tumor cell line, the concentrations of testosterone and StAR protein decreased. When FOXO3 and a StAR promoter vector were co-transfected into HEK293 cells for a reporter assay, FOXO3 inhibited the StAR promoter. Conclusion: FOXO3 affects testosterone synthesis by inhibiting the formation of StAR protein. LH hormone, meanwhile, influencesFoxo3 localization, mediating its function.
Abstract
Purpose: Foxo3 in female reproduction has been reported to regulate proliferation of granulose cells that form follicles. There are no reports so far that discuss on the role of Foxo3 in males. This study was designed to outline the role of Foxo3 in the testes. Materials and Methods: Testes from mice at birth to postpartum week (PPW) 5 were isolated and examined for the expression of Foxo3 using immunostaining. To elucidate role of Foxo3 in Leydig cells, R2C cells were treated with luteinizing hormone (LH) and the phosphorylation of Foxo3. Testosterone and steroidogenic acute regulatory (StAR) protein levels were measured after constitutive active [triple mutant (TM)] human FOXO3 adenovirus was transduced and StAR promoter assay was performed. Results: Foxo3 expression in the testicles started from birth and lasted until PPW 3. After PPW 3, most Foxo3 expression occurred in the nuclei of Leydig cells; however, at PPW 5, Foxo3 was expressed in both the nucleus and cytoplasm. When R2C cells were treated with luteinizing hormone, Foxo3 phosphorylation levels by AKT increased. After blocking the PI3K pathway, LH-induced phosphorylated Foxo3 levels decreased, indicating that LH signaling regulates Foxo3 localization. When active FOXO3-TM adenoviruswas introduced into a Leydig tumor cell line, the concentrations of testosterone and StAR protein decreased. When FOXO3 and a StAR promoter vector were co-transfected into HEK293 cells for a reporter assay, FOXO3 inhibited the StAR promoter. Conclusion: FOXO3 affects testosterone synthesis by inhibiting the formation of StAR protein. LH hormone, meanwhile, influencesFoxo3 localization, mediating its function.
참고문헌 (36)
- Huhtaniemi I, "Perspective: male reproduction", Endocrinology, 142, pp.2178~2183 (2001)
- Sharpe RM, "Proliferation and functional maturation of Sertoli cells, and their relevance to disorders of testis function in adulthood", Reproduction, 125, pp.769~784 (2003)
- Dierich A, "Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance", Proc Natl Acad Sci U S A, 95, pp.13612~13617 (1998)
- Purvis K, "Hormonal regulation of Leydig cell function", Mol Cell Endocrinol, 12, pp.123~138 (1978)
- Ma X, "Targeted disruption of luteinizing hormone beta-subunit leads to hypogonadism, defects in gonadal steroidogenesis, and infertility", Proc Natl Acad Sci U S A, 101, pp.17294~17299 (2004)
- Prathima Jasti, "Reproduction and Metabolism: Insights from Polycystic Ovary Syndrome", Endocrinology and Metabolism, 27(3), pp.180~190 (2012), 대한내분비학회
- Huang H, "Dynamic FoxO transcription factors", J Cell Sci, 120(Pt 15), pp.2479~2487 (2007)
- Lee EJ, "Targeted expression of toxic genes directed by pituitary hormone promoters:a potential strategy for adenovirus-mediated gene therapy of pituitary tumors", J Clin Endocrinol Metab, 84, pp.786~794 (1999)
- Tzivion G, "FoxO transcription factors;Regulation by AKT and 14-3-3 proteins", Biochim Biophys Acta, 1813, pp.1938~1945 (2011)
- Richards JS, "Expression of FKHR, FKHRL1, and AFX genes in the rodent ovary: evidence for regulation by IGF-I, estrogen, and the gonadotropins", Mol Endocrinol, 16, pp.580~599 (2002)
- Park Y, "Induction of cyclin D2 in rat granulosa cells requires FSH-dependent relief from FOXO1 repression coupled with positive signals from Smad", J Biol Chem, 280, pp.9135~9148 (2005)
- Hosaka T, "Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification", Proc Natl Acad Sci U S A, 101, pp.2975~2980 (2004)
- Matsuda F, "Expression and function of apoptosis initiator FOXO3 in granulosa cells during follicular atresia in pig ovaries", J Reprod Dev, 57, pp.151~158 (2011)
- Goertz MJ, "Foxo1 is required in mouse spermatogonial stem cells for their maintenance and the initiation of spermatogenesis", J Clin Invest, 121, pp.3456~3466 (2011)
- Castrillon DH, "Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a", Science, 301, pp.215~218 (2003)
- Lee EJ, "Splice variants of the forkhead box protein AFX exhibit dominant negative activity and inhibit AFXalpha-mediated tumor cell apoptosis", PLoS One, 3, pp.e2743~ (2008)
- Potente M, "11,12-Epoxyeicosatrienoic acid-induced inhibition of FOXO factors promotes endothelial proliferation by down-regulating p27Kip1", J Biol Chem, 278, pp.29619~29625 (2003)
- Hong ZY, "Inhibition of Akt", FOXO3a signaling by constitutively active FOXO3a suppresses growth of follicular thyroid cancer cell lines, 2012, pp.314, 34~40
- 김진욱, "Insulin Phosphorylates Tyrosine Residue 464 of Tub and Translocates Tubby into the Nucleus in HIRcB Cells", Endocrinology and Metabolism, 29(2), pp.163~168 (2014), 대한내분비학회
- Ketola I, "Expression of transcription factor GATA-4 during human testicular development and disease", J Clin Endocrinol Metab, 85, pp.3925~3931 (2000)
- Aspden WJ, "Changes in testicular steroidogenic acute regulatory (STAR) protein, steroidogenic enzymes and testicular morphology associated with increased testosterone secretion in bulls receiving the luteinizing hormone releasing hormone agonist deslorelin", Domest Anim Endocrinol, 15, pp.227~238 (1998)
- Wang XX, "Prediction of ovulation", Zhonghua Fu Chan Ke Za Zhi, 25, pp.86~88 (1990)
- Bäckström CT, "Pulsatile secretion of LH, FSH, prolactin, oestradiol and progesterone during the human menstrual cycle", Clin Endocrinol (Oxf), 17, pp.29~42 (1982)
- Erickson GF, "Stimulation of testosterone production in isolated rabbit thecal tissue by LH", FSH, dibutyryl cyclic AMP, PGE2alpha, and PGE2, 1976, pp.99, 452~458
- Palaniappan M, "Human chorionic gonadotropin stimulates theca-interstitial cell proliferation and cell cycle regulatory proteins by a cAMP-dependent activation of AKT", mTORC1signaling pathway, 2010, pp.24, 1782~1793
- Bogovich K, "Androgen biosynthesis in developing ovarian follicles: evidence that luteinizing hormone regulates thecal 17 alpha-hydroxylase and C17-20-lyase activities", Endocrinology, 111, pp.1201~1208 (1982)
- Magoffin DA, "Insulin-like growth factor-I selectively stimulates cholesterol side-chain cleavage expression in ovarian theca-interstitial cells", Mol Endocrinol, 4, pp.489~496 (1990)
- Magoffin DA, "Differentiation of ovarian theca-interstitial cells in vitro: regulation of 17 alpha-hydroxylase messenger ribonucleic acid expression by luteinizing hormone and insulinlike growth factor-I", Endocrinology, 132, pp.1945~1951 (1993)
- Magoffin DA, "Insulin-like growth factor-I stimulates the expression of 3 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid in ovarian theca-interstitial cells", Biol Reprod, 48, pp.1166~1173 (1993)
- Mizutani T, "Identification of a novel distal control region upstream of the human steroidogenic acute regulatory protein (StAR) gene that participates in SF-1-dependent chromatin architecture", J Biol Chem, 285, pp.28240~28251 (2010)
- Fukuda S, "Luteinizing hormone-induced Akt phosphorylation and androgen production are modulated by MAP Kinase in bovine theca cells", J Ovarian Res, 2, pp.17~ (2009)
- Shiraishi K, "Lutropin", choriogonadotropin stimulate the proliferation of primary cultures of rat Leydig cells through a pathway that involves activation of the extracellularly regulated kinase 1, Endocrinology, pp.2007, 148[DOI]
- Martinelle N, "Extracellular signal-regulated kinases are involved in the acute activation of steroidogenesis in immature rat Leydig cells by human chorionic gonadotropin", Endocrinology, 145, pp.4629~4634 (2004)
- Stocco DM, "Role of the steroidogenic acute regulatory protein (StAR) in steroidogenesis", Biochem Pharmacol, 51, pp.197~205 (1996)
- Murayama C, "Luteinizing hormone (LH) regulates production of androstenedione and progesterone via control of histone acetylation of StAR and CYP17 promoters in ovarian theca cells", Mol Cell Endocrinol, 350, pp.1~9 (2012)
- Wang G, "Development of leydig cells in the insulin-like growth factor-I (igf-I) knockout mouse: effects of igf-I replacement and gonadotropic stimulation", Biol Reprod, 70, pp.632~639 (2004)
